• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迟发性术后神经功能缺损患者:病例报告。

Delayed Onset Post-Operative Neurologic Deficit in a Patient With Mucopolysaccharidosis type VI: A Case Report.

机构信息

Department of Orthopedics and Rehabilitation, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.

出版信息

Iowa Orthop J. 2022;42(2):122-127.

PMID:36601232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9769351/
Abstract

BACKGROUND

Mucopolysaccharidoses (MPS) are lysosomal storage disorders characterized by abnormal deposition of glycosaminoglycans (GAGs) in tissues. In type VI MPS, otherwise known as Maroteaux-Lamy syndrome, the defect is in the enzyme N-acetylgalactosamine-4-sulfatase. Thoracolumbar kyphosis results from GAG deposition, leading to incompetence of posterior ligamentous structures as well as poor trunk control. Though neurologic symptoms from canal compression due to deformity and hypertrophy of tissues have been described, occasionally requiring surgical decompression, there has not been a prior report of late onset of symptoms in a previously neurologically intact patient following surgery to correct spine deformity.

METHODS

The case reviewed is a 14 year old girl with mucopolysaccharidosis type VI underwent anterior release and posterior instrumentation for correction of severe progressive lumbar kyphosis. Postoperatively she developed delayed onset of profound lower extremity weakness and underwent urgent wide laminectomies and resection of thickened ligamentum flavum. At 1 year follow-up, she had near complete neurologic recovery.

CONCLUSION

Patients with mucopolysacchari-doses are at significant risk for neurologic compromise both as part of the natural history of the disease, and as a risk of deformity correction. The surgeon must consider the pathologic thickening of tissues surrounding the spinal cord when planning surgery. .

摘要

背景

黏多糖贮积症(MPS)是一种溶酶体贮积病,其特征是组织中糖胺聚糖(GAG)异常沉积。在 6 型黏多糖贮积症(也称为 Maroteaux-Lamy 综合征)中,缺陷在于 N-乙酰半乳糖胺-4-硫酸酯酶。由于 GAG 沉积导致胸腰椎后凸,导致后韧带结构失能以及躯干控制能力差。尽管由于组织畸形和肥大导致的管腔压迫引起的神经症状已有描述,偶尔需要手术减压,但在先前神经功能完整的患者中,脊柱畸形矫正手术后出现症状迟发的情况尚无报道。

方法

回顾的病例是一名 14 岁女孩,患有黏多糖贮积症 6 型,接受前路松解和后路器械固定以矫正严重的进行性腰椎后凸。术后她出现了迟发性严重下肢无力,并接受了紧急广泛椎板切除术和增厚的黄韧带切除术。在 1 年的随访中,她几乎完全恢复了神经功能。

结论

黏多糖贮积症患者存在神经功能受损的风险,包括疾病自然史和畸形矫正的风险。在计划手术时,外科医生必须考虑围绕脊髓的组织病理性增厚。

相似文献

1
Delayed Onset Post-Operative Neurologic Deficit in a Patient With Mucopolysaccharidosis type VI: A Case Report.迟发性术后神经功能缺损患者:病例报告。
Iowa Orthop J. 2022;42(2):122-127.
2
Pediatric cervical kyphosis in the MRI era (1984-2008) with long-term follow up: literature review.MRI 时代(1984-2008 年)的儿童颈椎后凸:文献回顾。
Childs Nerv Syst. 2022 Feb;38(2):361-377. doi: 10.1007/s00381-021-05409-z. Epub 2021 Nov 22.
3
Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): a Y210C mutation causes either altered protein handling or altered protein function of N-acetylgalactosamine 4-sulfatase at multiple points in the vacuolar network.黏多糖贮积症VI型(马罗-拉米综合征):Y210C突变导致N-乙酰半乳糖胺4-硫酸酯酶在液泡网络的多个位点出现蛋白处理改变或蛋白功能改变。
Biochemistry. 2002 Apr 16;41(15):4962-71. doi: 10.1021/bi0121149.
4
Mucopolysaccharidosis type VI: case report with first neonatal presentation with ascites fetalis and rapidly progressive cardiac manifestation.黏多糖贮积症 VI 型:一例以胎儿腹水和快速进展性心脏表现为首发表现的新生儿病例报告。
BMC Med Genet. 2020 Feb 19;21(1):37. doi: 10.1186/s12881-020-0972-y.
5
Intrathecal administration of recombinant human N-acetylgalactosamine 4-sulfatase to a MPS VI patient with pachymeningitis cervicalis.鞘内注射重组人 N-乙酰半乳糖胺 4-硫酸酯酶治疗伴颈椎脊膜肥厚的 MPS VI 患者。
Mol Genet Metab. 2010 Apr;99(4):346-50. doi: 10.1016/j.ymgme.2009.11.008. Epub 2009 Dec 5.
6
Pharmacodynamics, pharmacokinetics and biodistribution of recombinant human N-acetylgalactosamine 4-sulfatase after 6months of therapy in cats using different IV infusion durations.使用不同静脉输注时长对猫进行6个月治疗后重组人N-乙酰半乳糖胺4-硫酸酯酶的药效学、药代动力学和生物分布
Mol Genet Metab. 2016 Feb;117(2):157-63. doi: 10.1016/j.ymgme.2015.10.006. Epub 2015 Oct 21.
7
Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI): a single dose of galsulfase further reduces urine glycosaminoglycans after hematopoietic stem cell transplantation.Maroteaux-Lamy 综合征(黏多糖贮积症 VI 型):单次给予 galase 酶后,造血干细胞移植后尿液糖胺聚糖进一步降低。
Mol Genet Metab. 2010 Dec;101(4):346-8. doi: 10.1016/j.ymgme.2010.07.015. Epub 2010 Aug 1.
8
Natural history and galsulfase treatment in mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy syndrome)--10-year follow-up of patients who previously participated in an MPS VI Survey Study.黏多糖贮积症VI型(MPS VI,马罗托-拉米综合征)的自然病史及加硫酶治疗——曾参与MPS VI调查研究患者的10年随访
Am J Med Genet A. 2014 Aug;164A(8):1953-64. doi: 10.1002/ajmg.a.36584. Epub 2014 Apr 24.
9
Compressive myelopathy associated with type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome).与VI型黏多糖贮积症(马罗-拉米综合征)相关的压迫性脊髓病
Neurosurgery. 1984 Jan;14(1):83-8. doi: 10.1227/00006123-198401000-00020.
10
[Analysis of clinical features and arylsulfatase B gene mutation in thirteen Chinese children with mucopolysaccharidosis type VI].[13例中国黏多糖贮积症Ⅵ型患儿临床特征及芳基硫酸酯酶B基因突变分析]
Zhonghua Er Ke Za Zhi. 2014 Jun;52(6):403-8.

本文引用的文献

1
Clinical Manifestations and Surgical Management of Spinal Lesions in Patients With Mucopolysaccharidosis: A Report of 52 Cases.黏多糖贮积症患者脊柱病变的临床表现及外科治疗:52例报告
Spine Deform. 2019 Mar;7(2):298-303. doi: 10.1016/j.jspd.2018.07.005.
2
Spine challenges in mucopolysaccharidosis.黏多糖贮积症的脊柱挑战。
Int Orthop. 2019 Jan;43(1):159-167. doi: 10.1007/s00264-018-4143-0. Epub 2018 Sep 14.
3
Mucopolysaccharidosis type VI (MPS VI) and molecular analysis: Review and classification of published variants in the ARSB gene.黏多糖贮积症 VI 型(MPS VI)及分子分析:ARSB 基因已发表变异的综述和分类。
Hum Mutat. 2018 Dec;39(12):1788-1802. doi: 10.1002/humu.23613. Epub 2018 Sep 17.
4
Epidemiology of mucopolysaccharidoses.黏多糖贮积症的流行病学
Mol Genet Metab. 2017 Jul;121(3):227-240. doi: 10.1016/j.ymgme.2017.05.016. Epub 2017 May 26.
5
Surgical Management of Thoracolumbar Kyphosis in Patients With Mucopolysaccharidosis: A Systematic Review.《黏多糖贮积症患者胸腰椎后凸畸形的手术治疗:系统评价》
Spine (Phila Pa 1976). 2017 Dec 1;42(23):1817-1825. doi: 10.1097/BRS.0000000000002242.
6
Surgical Management of Progressive Thoracolumbar Kyphosis in Mucopolysaccharidosis: Is a Posterior-only Approach Safe and Effective?黏多糖贮积症中进行性胸腰椎后凸的手术治疗:单纯后路手术方法安全有效吗?
J Pediatr Orthop. 2018 Aug;38(7):354-359. doi: 10.1097/BPO.0000000000000826.
7
Enzyme replacement therapy with galsulfase for mucopolysaccharidosis type VI.用加硫酶进行的酶替代疗法治疗黏多糖贮积症VI型。
Cochrane Database Syst Rev. 2016 Mar 4;3:CD009806. doi: 10.1002/14651858.CD009806.pub2.
8
Thoracolumbar kyphosis in patients with mucopolysaccharidoses: clinical outcomes and predictive radiographic factors for progression of deformity.黏多糖贮积症患者的胸腰椎后凸:临床结果及畸形进展的预测性影像学因素
Bone Joint J. 2016 Feb;98-B(2):229-37. doi: 10.1302/0301-620X.98B2.36144.
9
Perioperative medullary complications in spinal and extra-spinal surgery in mucopolysaccharidosis: a case series of three patients.黏多糖贮积症患者脊柱及脊柱外手术围手术期的髓质并发症:3例病例系列报道
JIMD Rep. 2014;16:95-9. doi: 10.1007/8904_2014_325. Epub 2014 Jul 20.
10
Combined spinal arthrodesis with instrumentation for the management of progressive thoracolumbar kyphosis in children with mucopolysaccharidosis.联合脊柱融合术及器械治疗儿童黏多糖贮积症所致的进行性胸腰椎后凸畸形
Eur Spine J. 2014 Dec;23(12):2751-7. doi: 10.1007/s00586-014-3186-1. Epub 2014 Jan 28.